SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Stock from a lonely pharmacist's view

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: Terry Laws who wrote (11)5/17/1998 11:27:00 AM
From: Shake-Man   of 12
 
Unfortunately, at the time I started investing I didn't have enough spare cash to buy a worthwhile amount of MYL (too soon after Xmas). It was at 18 at the time. I had been told by an informed source that it would hit 30 by the end of May. He was dead on. He is my new best friend. I wish now that I had borrowed the money.

That same source assures me that Duramed will jump to the the mid-20's as soon as its conjugated estrogen is approved. It's lingering around 6 now, so it wouldn't be too expensive to get some. I have some stock in it, and Mylan's recent success leads me to believe that Duramed will yield me some extra change this Christmas. He told me the other day that SCIO would hit 30 as soon as its congestive heart failure drug was approved. It's at 12 1/2 right now. I am thinking about selling a kidney to buy some of it. I haven't decided yet. All I know is that I need for some of my stocks to do something soon because my credit card bill is due in the mailbox any day now.

Chicks really dig me,
Shake-Man
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext